A Central Contribution of TG2 Activity to the Antiproliferative and Pro-Apoptotic Effects of Caffeic Acid in K562 Cells of Human Chronic Myeloid Leukemia.

Feriotto, Giordana; Tagliati, Federico; Brunello, Arianna; Beninati, Simone; Tabolacci, Claudio; Mischiati, Carlo

Feriotto, Giordana; Tagliati, Federico; Brunello, Arianna; Beninati, Simone; Tabolacci, Claudio; Mischiati, Carlo.

Afiliación

Feriotto G; Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, 44121 Ferrara, Italy.
Tagliati F; Department of Neuroscience and Rehabilitation, University of Ferrara, 44121 Ferrara, Italy.
Brunello A; Department of Neuroscience and Rehabilitation, University of Ferrara, 44121 Ferrara, Italy.
Beninati S; Department of Biology, University of Rome "Tor Vergata", 00133 Rome, Italy.
Tabolacci C; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, 00161 Rome, Italy.
Mischiati C; Department of Neuroscience and Rehabilitation, University of Ferrara, 44121 Ferrara, Italy.

Int J Mol Sci ; 23(23)2022 Nov 30.

Article en En | MEDLINE | ID: mdl-36499332

Asunto(s)

Leucemia Mielógena Crónica BCR-ABL Positiva; Humanos; Células K562; Leucemia Mielógena Crónica BCR-ABL Positiva/tratamiento farmacológico; Leucemia Mielógena Crónica BCR-ABL Positiva/genética; Leucemia Mielógena Crónica BCR-ABL Positiva/metabolismo; Mesilato de Imatinib/farmacología; Mesilato de Imatinib/uso terapéutico; Ácidos Cafeicos/farmacología; Ácidos Cafeicos/uso terapéutico; Apoptosis; Resistencia a Antineoplásicos

Palabras clave

Chronic Myeloid Leukemia; natural molecules; transglutaminase type 2

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva Idioma: En Revista: Int J Mol Sci Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google